tirzepatide and tamoxifen Scientists have discovered that tirzepatide—an FDA-approved drug for diabetes weight loss (Mounjaro, Zepbound)—can also shrink breast cancer tumors in obese mice. Presented at ENDO 2025, the University of Michigan study showed Tirzepatide | TrimRx

Whether a company manufactures products synthetically often depends on its current capabilities

But when it comes to satisfying key consumer trends, two major stumbling blocks are holding the market back: its difficult to add lots of protein without a negative impact on texture, and its tricky to create cereal bars that are not high in sugar.

The databases used were Pubmed, Scopus and Cochrane

Combining this approach with strategic meal planning and trusted support raises your odds of long-term success

Nausea is a common early side effect of semaglutide therapy that typically peaks in the first 2-4 weeks and improves as your body adjusts